Status:
COMPLETED
Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis
Lead Sponsor:
Rasmia Elgohary
Conditions:
Osteo Arthritis Knee
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
the study was conducted on 31-patients with symptomatic primary knee osteoarthritis. The patients were randomized into intervention and control groups. The control group was kept on their medications ...
Detailed Description
the study included 31 patients with symptomatic primary knee osteoarthritis (KOA) The study group was randomized into an intervention group and a control one. The control group patients were kept on t...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Clinical and radiographic diagnosis of primary knee osteoarthritis
- Patients must be symptomatic
- Exclusion Criteria:
- Patients with secondary knee osteoarthritis
- previous intra-articular steroid, or hyaluronic knee injection in last year
- Patients with other disabling lower limb osteoarthropathy or myopathy
Exclusion
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2018
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04331327
Start Date
May 1 2017
End Date
April 28 2018
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
rheumatology and clinical immunology unit of internal medicine department of Kasr Al-ainy Hospital, Cairo University
Cairo, Egypt, 11562